Literature DB >> 12656663

Magnetic resonance imaging study of pituitary morphology in subjects homozygous and heterozygous for a null mutation of the GHRH receptor gene.

Helio A Oliveira1, Roberto Salvatori, Miriam P O Krauss, Carla R P Oliveira, Paula R C Silva, Manuel H Aguiar-Oliveira.   

Abstract

OBJECTIVE: Somatotrophs represent the majority of cells in the anterior pituitary, and their numeric reduction can cause anterior pituitary hypoplasia (APH). Small numbers of patients with familial isolated GH deficiency (IGHD) due to bi-allelic mutations in the GHRH receptor (GHRHR) gene (GHRHR) have been reported to have APH. We tested if APH was present in a large cohort of patients homozygous and heterozygous for a GHRHR mutation.
DESIGN: We studied pituitary morphology in adult and pediatric age subjects (8 years of age and older) belonging to a large extended Brazilian kindred with a high prevalence of IGHD due to a null GHRHR mutation.
METHODS: We performed brain magnetic resonance imaging (MRI) in 38 subjects, divided into four groups: group I: normal adults (five males, four females, age 38+/-11.7 years); group II: heterozygous adults (six males, seven females, age 42.23+/-8.8 years); group III: homozygous GH-naive affected adults (three males, five females, age 41.4+/-15.0 years); group IV: homozygous affected children (three males, five females, age 11.9+/-2.5 years). Results are expressed as means+/-s.d.
RESULTS: Pituitary height (mm) was not different between groups II and I (4.61+/-1.55 and 4.41+/-0.62 respectively), but it was significantly reduced in groups III (2.67+/-0.87, P<0.001) and IV (2.87+/-0.79, P<0.001) compared with group I. Pituitary volume (mm(3)) was normal in group II (417.12+/-140.86), but it was significantly reduced in groups III and IV (124.06+/-64.27 and 155.68+/-39.79 respectively vs 414.56+/-71.57; both P<0.001). The volume ratio (calculated by multiplying the pituitary volume by 1000 and dividing it by cranial volume) was significantly lower in the affected subjects (groups III and IV) (0.06+/-0.02) than in unaffected (groups I and II) (0.15+/-0.04; P<0.0001), demonstrating that APH is not due to reduction of cranial volume.
CONCLUSIONS: APH is present from childhood in patients homozygous for an inactivating GHRHR mutation, but it does not occur in heterozygous subjects. In our cohort, the presence of normal anterior pituitary size by MRI rules out homozygosity for a GHRHR mutation in subjects who are 8 years of age or older.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12656663     DOI: 10.1530/eje.0.1480427

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  15 in total

Review 1.  Growth hormone and IGF-1.

Authors:  Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

2.  GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome.

Authors:  R Salvatori; M G Serpa; G Parmigiani; A V O Britto; J L M Oliveira; C R P Oliveira; C M Prado; C T Farias; J C Almeida; T A R Vicente; M H Aguiar-Oliveira
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

3.  Sizes of abdominal organs in adults with severe short stature due to severe, untreated, congenital GH deficiency caused by a homozygous mutation in the GHRH receptor gene.

Authors:  Carla R P Oliveira; Roberto Salvatori; Luciana M A Nóbrega; Erick O M Carvalho; Menilson Menezes; Catarine T Farias; Allan V O Britto; Rossana M C Pereira; Manuel H Aguiar-Oliveira
Journal:  Clin Endocrinol (Oxf)       Date:  2008-07-01       Impact factor: 3.478

Review 4.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

5.  Unusual phenotypic features in a patient with a novel splice mutation in the GHRHR gene.

Authors:  Latifa Hilal; Yassir Hajaji; Marie-Pierre Vie-Luton; Zeina Ajaltouni; Bouchra Benazzouz; Maha Chana; Adelmajid Chraïbi; Abdelkrim Kadiri; Serge Amselem; Marie-Laure Sobrier
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

6.  Evaluation of anterior pituitary gland volume in childhood using three-dimensional MRI.

Authors:  Simone Marziali; Fabrizio Gaudiello; Alessandro Bozzao; Giuseppe Scirè; Ernesto Ferone; Vittorio Colangelo; Alessandra Simonetti; Brunetto Boscherini; Roberto Floris; Giovanni Simonetti
Journal:  Pediatr Radiol       Date:  2004-04-28

Review 7.  Magnetic resonance imaging of the hypothalamus-pituitary unit in childrensuspected of hypopituitarism: who, how and when toinvestigate.

Authors:  M Maghnie; S Ghirardello; E Genovese
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

8.  Laryngeal and vocal evaluation in untreated growth hormone deficient adults.

Authors:  Valéria M P Barreto; Jeferson S D'Avila; Neuza J Sales; Maria Inês R Gonçalves; Juliane Dantas Seabra; Roberto Salvatori; Manuel H Aguiar-Oliveira
Journal:  Otolaryngol Head Neck Surg       Date:  2009-01       Impact factor: 3.497

9.  Prolactin and sex steroids levels in congenital lifetime isolated GH deficiency.

Authors:  Menilson Menezes; Roberto Salvatori; Luiza D Melo; Ívina E S Rocha; Carla R P Oliveira; Rossana M C Pereira; Anita H O Souza; Eugênia H O Valença; Enaldo V Melo; Viviane C Campos; Flavia O Costa; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2013-02-10       Impact factor: 3.633

10.  Climacteric in untreated isolated growth hormone deficiency.

Authors:  Menilson Menezes; Roberto Salvatori; Carla R P Oliveira; Rossana M C Pereira; Anita H O Souza; Luciana M A Nobrega; Edla A C Cruz; Marcos Menezes; Erica O Alves; Manuel H Aguiar-Oliveira
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.